Angel Qin, MD, identified the critical role of immunotherapy timing and shared decision-making in small cell lung cancer ...

Fetal alcohol syndrome (FAS) is 100% preventable as an environmental cause of intellectual disability and represents the most ...

Alina Salganicoff, PhD, discusses the immediate effects of the budget cuts to Medicaid as it pertains to women's health ...

A new partnership delivers a scalable Fast Healthcare Interoperability Resources solution to help payers meet CMS' ...

A real-world study found that semaglutide prescriptions were associated with improvements in weight, blood pressure, and ...

Christina Poh, MD, of City of Hope National Medical Center, highlights the benefit of tafasitamab in improving progression-free survival for heavily pretreated patients with relapsed or refractory ...

Panelists discuss how economic models must account for the broader impact of MS progression on earning potential, family planning, caregiver burden, and quality of life rather than focusing solely on ...

Left bundle branch block may serve as an important indicator for asymptomatic individuals predisposed to heart failure.

The QRISK3 assessment is designed for the general population, but it appears to also have utility in patients with essential thrombosis and polycythemia vera.

The FDA approved multiple groundbreaking treatments in July, enhancing options across patient populations. The FDA maintained its momentum in July, issuing a wave of drug approvals across diverse ...

Social drivers of health are determined primarily by an individual’s economic stability, access to quality education, and health care. These factors also play a key role in the proportion of ...

Panelists discuss the timely initiation of biologic therapy in moderate to severe hidradenitis suppurativa, emphasizing individualized treatment decisions based on disease impact and quality of life, ...